According to data presented at the annual meeting of the American Association for the Advancement of Science, a specially developed cocoa, designed to retain naturallyoccurring compounds called flavanols, may have a role in preventing cognitive decline and dementia. The findings suggest that a diet rich in flavanols may improve blood-vessel function, and that these benefits extend to the brain and may therefore have important implications for learning and memory.
Several trials reach same conclusion
Data from several studies were presented at the meeting during a session entitled "The Neurobiology of Chocolate: A mind altering experience?" One trial, conducted by Ian Macdonald and his group at the University of Nottingham Medical School in the UK, revealed that consumption of cocoa resulted in regional changes in blood flow. Dr Macdonald and his team concluded that cocoa flavanols may have therapeutic potential for the treatment of vascular impairments within the brain.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze